SOLV
Solventum Corp.
88.40$
-0.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.5% | +5.5% | -0.9% | +1.1% | -2.0% | +0.5% | +3.8% | -7.3% | +2.3% | -1.4% | +1.0% | |
| – | -5.2% | +33.3% | +0.1% | -0.3% | -3.1% | -6.0% | +5.1% | +37.4% | -12.4% | -7.2% | +4.4% | |
| – | -61.2% | +413.4% | -9.9% | -13.9% | -1.3% | -29.9% | -7.9% | +233.7% | -46.5% | -36.1% | -28.2% | |
| – | -61.2% | +413.4% | -9.9% | -13.9% | -1.3% | -29.9% | -7.9% | +233.7% | -46.5% | -36.1% | -28.2% | |
| – | +13.9% | -7.1% | +8.0% | -16.1% | +11.2% | -9.6% | +13.0% | -18.8% | +1.5% | +2.4% | +35.2% | |
| – | +0.9% | +5.1% | -0.2% | +6.0% | +1.3% | -10.3% | +11.1% | +9.0% | +1.6% | +2.2% | -4.5% | |
| – | +2.1% | -1.0% | -0.3% | +2.2% | -3.3% | -21.7% | +5.7% | -0.3% | +8.4% | -1.4% | +0.0% | |
| – | -2.5% | -3.2% | -3.1% | -2.7% | -4.0% | -7.0% | -2.7% | -3.4% | +16.6% | -3.7% | -3.6% | |
| – | -78.6% | +376.9% | +7.8% | -1.3% | -0.5% | -2.0% | +1.5% | -21.4% | +2.9% | -1.3% | +3.5% | |
| – | +17.5% | +7.3% | +38.7% | +13.0% | -6.9% | -5.1% | +2.1% | +12.1% | +6.7% | +6.7% | +9.5% | |
| – | – | – | – | -50.9% | -33.3% | -50.0% | – | – | – | – | +0.2% | |
| – | +26.5% | +23.1% | -15.7% | +13.1% | +10.4% | -2.3% | +6.5% | +4.0% | +2.7% | +1.7% | +0.3% | |
| – | -0.3% | +0.0% | +0.0% | -6.0% | +0.0% | +0.0% | +0.0% | -34.3% | -2.0% | -9.1% | 0.0% | |
| – | +259.0% | -67.0% | -25.6% | +11.3% | -7.3% | +10.2% | +11.7% | +36.8% | +1.3% | -1.6% | -3.4% | |
| – | – | – | – | +137.1% | +14.7% | +56.2% | +23.8% | +270.5% | +3.6% | +0.7% | +5.1% | |
| – | +0.0% | +0.0% | +0.5% | +0.2% | +0.3% | +0.2% | +0.2% | +0.1% | -0.1% | +0.1% | -0.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.